Everyone is looking to attract new companies. And Antares (AMEX:AIS) is looking for a new home. The drug developer and medical device business has “maxed out” its office space in Ewing, N.J. But good luck getting the company to move its headquarters far. Paul Wotton, Antares’ CEO said he is keen to keep the company in the region because that’s where his employees live. The company currently has two locations — an engineering facility in Minneapolis and a corporate headquarters in Ewing that also houses its clinical and regulatory teams. The lease for its New Jersey office expires in January 2012.
